Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy
SAN CARLOS, Calif.–(BUSINESS WIRE)–Dren Bio, a privately held, clinical-stage biotechnology company developing first-in-class myeloid cell engager therapeutics, announced today that it has entered into a strategic collaboration with Sanofi (NASDAQ: SNY) for the discovery and development of a next-generation B-cell depleting therapy for the treatment of various autoimmune diseases. The new agreement builds on the […]
GSK spins out corporate VC fund focused on bioelectronic tech
GSK has offloaded a corporate venture unit that invests in bioelectronic startups working on neuromodulation, wearables, implanted devices and other technology, Endpoints News has learned. The VC unit, Action Potential Venture Capital (APVC), launched with $50 million from GSK in 2013, when it made its first investment in SetPoint Medical, creator of an implantable device […]
Carrick Therapeutics Announces Positive Results from Phase 2 Randomized Trial of Samuraciclib in Combination with Fulvestrant in Patients with Hormone Receptor Positive, HER2 Negative Advanced Breast Cancer
BOSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) — Carrick Therapeutics Inc., an oncology-focused biopharmaceutical company discovering and developing highly differentiated therapies, today announced positive results from the Phase 2 SUMIT-BC clinical trial evaluating samuraciclib in combination with fulvestrant in patients with second-line advanced hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) […]
YPrime Wins Two Clinical Trials Arena Excellence Awards for Innovation in AI and Sustainable Practices
MALVERN, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) — YPrime, a proven leader in clinical trial technology, today announced it has received two distinctions in the 2025 Clinical Trials Arena Excellence Awards: Innovation for AI in Clinical Trials and Environmental Excellence for Sustainable Trials. Powered by GlobalData’s independent research, the Clinical Trials Arena Excellence Awards recognize organizations […]
Celebrating Over Ten Years of Success in Healthcare
We are excited to celebrate over a decade of remarkable growth and success at Revelation Partners—made possible by the enduring partnership and support of our limited partners, trusted counterparties, and friends of the firm. Over the past ten years, our team and platform have expanded significantly, and we are deeply grateful to everyone who has […]
Bluejay Capital Partners Recapitalizes Quality Life Science Logistics & Transportation
DENVER & COOPERSVILLE, Mich., December 02, 2025–(BUSINESS WIRE)–Bluejay Capital Partners, LLC (Bluejay Capital), a specialist in partnering and investing in transportation and logistics businesses, has recapitalized Quality Life Science Logistics & Transportation (QLS), a premier provider of specialized cold chain transportation and logistics solutions for the pharmaceutical and life sciences industries. Terms of the transaction were not disclosed. […]
Aspen enriches Parkinson’s cell therapy trial with Kite-backed $115M series C
Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ongoing trial of a regenerative cell therapy for Parkinson’s disease. The raise will power Aspen’s phase 1/2 study of ANPD001, a therapy that turns patients’ skin cells into new neurons that are then transplanted into their brains to […]
Healthcare-Focused Secondaries Manager Revelation Partners Expands Investment Team, Promotes Eric Shiozaki to Partner
Revelation Partners, a leading investment manager in the healthcare secondaries market, today announced the appointment of Eric Shiozaki, Ph.D. as a partner. Shiozaki joined the firm in 2024 as a venture partner and focuses on investment opportunities in biotech and medical devices. Sausalito, Calif.-based Revelation Partners manages more than $1.5 billion in committed capital and provides liquidity […]
Five Takeaways on the State of AI in Healthcare from HLTH 2025
Healthcare’s AI Moment is Here—and it’s Operational HLTH 2025 made one thing unmistakably clear: healthcare’s AI era is no longer about pilots or prototypes—it’s about productivity. Across every panel and conversation, the message was the same: AI is moving from concept to infrastructure. Clinicians, executives, and investors agreed that the technology’s value is finally being […]
Betting on the Backbone: Investing in Payer IT
Healthcare insurers sit at the center of the U.S. healthcare system, controlling nearly 90 cents of every healthcare dollar[1]. Yet despite their scale and influence, the nation’s largest payers (e.g. Humana, CVS, UnitedHealthcare, etc.) are facing unprecedented pressure. Stock prices for the major insurers have dropped 15–55% since early 2023, even as the overall market […]